ArticleBMC infectious diseases2012

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation.

Michaela Döring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.